4Reiter A,Schrappe M,Tiemann M,et al.Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy:A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.Blood,1999,94(10):3294-3306
5Seidemann K,Tiemann M,Schrappe M,et al.Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma:a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.Blood,2001,97(12):3699-3706
6Murphy SB.Classification,staging and end results of treatment of childhood non-Hodgkin's lymphomas:dissimilarities from lymphomas in adults.Semin Oncol,1980,7(3):332-339
7Woessmann W,Seidemann K,Mann G,et al.The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms:a report of the BFM Group Study NHL-BFM95.Blood,2005,105(3):948-958
8Patte C,Auperin A,Gerrard M,et al.Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents:it is possible to reduce treatment for the early responding patients.Blood,2007,109(7):2773-2780
9Pillon M,Di Tullio MT,Garaventa A,et al.Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92).Cancer,2004,101(2):385-394
10Brugibres L, Le Deley MC, Rosolen A, et al. Impact of themethotrexate administration dose on the need for intratheeal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the E1CNHL Group. J Clin Onco1,2009,27 : 897-903.
